Clinical Trial Update: Sepraspray™ Laparoscopic Myomectomy Study [NA]

View source ↗

Summary

Clinical trial Sepraspray for laparoscopic myomectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Sepraspray

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Laparoscopic Myomectomy | NA | Status: COMPLETED